Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPercutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation
American Journal of Otolaryngology, 07/10/09
Lawson JD et al. - In a study to examine the toxicities associated with feeding tube placement and predictors for duration of tube dependence, it was shown that feeding tubes are required for >2 mos after combined modality treatment of head and neck cancer (HNC). They are generally well tolerated, but toxicities are not trivial: >10% require replacement and >8% of pts develop infection at the insertion site.
Methods- Records were reviewed for pts receiving definitive radiotherapy between 6/1/2003 and 6/1/2006.
- Records of the subset of pts with feeding tube placement before initiation of therapy were reviewed for toxicities as well as length of time of tube dependence.
- There were 102 eligible pts.
- Radiotherapy was delivered with concomitant chemotherapy in all.
- Median time with feeding tube in place for all pts was 4.4 mos.
- For 82 pts with eventual tube removal, median time of tube dependence was 3.8 mos.
- Risk factors for prolonged tube dependence are analyzed; on multivariate analysis, pt age, T stage, and nodal status remained significant.
- Most common complication was tube replacement, with 11.8% of all tubes requiring replacement.
- Infection and pain occurred in 8.8% and 5.9% of pts, respectively.
Related Articles
Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 71%
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 71%
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09
Relevance Score: 69%
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 69%
Progesterone receptors identified in vascular malformations of the head and neck
Otolaryngology Head and Neck Surgery, 10/09/09
Relevance Score: 69%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue
Oral Oncology , 12/19/09
Disruption of Transforming Growth Factor-beta Signaling by Five Frequently Methylated Genes Leads to Head and Neck Squamous Cell Carcinoma Pathogenesis
Cancer Research, 12/19/09
Expression of p16 in benign and malignant cystic squamous lesions of the neck
Human Pathology, 12/19/09
Today in Pain Management/Palliative Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Provision of Spiritual Care to Patients With Advanced Cancer: Associations With Medical Care and Quality of Life Near Death
Journal of Clinical Oncology, 12/19/09
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor